Rocket Lab Stock Approaches Key Threshold Amid Analyst Optimism

The shares of Rocket Lab USA continue their impressive ascent, now closing in on the significant $100 mark following a substantial rally. Since the start of the year, the stock has surged approximately 38%, building on prior momentum. The driving forces behind this move extend beyond technical factors, anchored instead by a recent analyst endorsement and a robust fundamental outlook for the aerospace firm.

Fundamental Performance and Contract Wins

Underpinning the bullish sentiment is strong operational performance. The company reported record third-quarter 2025 revenue of $155 million, representing a 48% increase year-over-year. Its backlog across Launch and Space Systems has now swelled to over $1.1 billion.

Notable recent contract awards have significantly contributed to this growth. In December 2025, Rocket Lab secured an agreement with the Space Development Agency for the design and manufacture of 18 satellites, a deal valued at $816 million with a potential total value reaching up to $1 billion. Furthermore, the company has gained a place in the MACH-TB 2.0 hypersonic testing program.

Analyst Upgrade Provides Fresh Catalyst

A key accelerant for the recent price action was provided by Morgan Stanley on January 16. The investment bank upgraded its rating on the stock from “Equal Weight” to “Overweight” and raised its price target considerably from $67 to $105. This new target suggests a further upside potential of around 10% from current levels.

The firm’s analysts cited several reasons for their optimistic stance:
* An anticipated increase in launch frequency.
* The upcoming introduction of new products, specifically the Neutron rocket.
* Supportive political tailwinds for the space sector.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Morgan Stanley’s research indicates the industry will remain highly attractive through the end of 2026, highlighting growing institutional interest in established players like Rocket Lab.

The Neutron Rocket: A Pivotal Future Driver

Central to the company’s long-term strategy is the development of its reusable Neutron launch vehicle. This rocket is designed to position Rocket Lab as a direct competitor to SpaceX’s Falcon 9, particularly in the lucrative market for deploying mega-constellations. Management is targeting the Neutron’s inaugural launch for the first quarter of 2026, pending successful completion of final qualifications. Three missions for the new rocket are already firmly booked.

Market speculation regarding a potential SpaceX initial public offering (IPO) near the end of 2026 has also provided a valuation tailwind. Rumors of a possible $1.5 trillion valuation for SpaceX have made investors more willing to assign higher valuation multiples to publicly traded competitors such as Rocket Lab.

Valuation and Profitability Considerations

Despite these operational advances, the stock’s valuation remains ambitious. Rocket Lab currently trades at 85 times its expected sales and continues to operate at a loss. Its operating losses for Q3 2025 stood at $59 million, remaining at an elevated level. While research and development costs for the Neutron program are a primary pressure on margins, management has signaled that these expenditures may soon peak.

In the near term, market attention is focused on the first planned Electron launch of the year. Technical readiness for today’s attempt has been confirmed, though weather conditions remain a variable. Medium-term, however, the successful maiden flight of the Neutron rocket will be the decisive factor in determining whether the company can grow into its ambitious valuation.